Targeted Imaging of Lung Cancer with Hyperpolarized <sup>129</sup>Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents

Targeted Imaging of Lung Cancer with Hyperpolarized <sup>129</sup>Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents

Hyperpolarized <sup>129</sup>Xe (HP <sup>129</sup>Xe) MRI enables functional imaging of various lung diseases but has been scarcely applied to lung cancer imaging. The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP <sup>12...

Full description

Bibliographic Details
Main Authors: Atsuomi Kimura, Seiya Utsumi, Akihiro Shimokawa, Renya Nishimori, Rie Hosoi, Neil J. Stewart, Hirohiko Imai, Hideaki Fujiwara
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
hyperpolarized <sup>129</sup>Xe MRI
murine lung cancer
targeted imaging
molecular targeting contrast agent
Online Access:https://www.mdpi.com/2072-6694/14/24/6070

Internet

https://www.mdpi.com/2072-6694/14/24/6070

Similar Items